| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |